American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
Abstract The American Cancer Society (ACS) has developed guidelines for the use of the
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …
Measurement of subjective phenomena in primary care research: the Visual Analogue Scale.
MD Miller, DG Ferris - Family practice research journal, 1993 - europepmc.org
The visual analogue scale is a technique used to measure subjective phenomena. It is a self-
reporting device consisting of a line of predetermined length that separates extreme …
reporting device consisting of a line of predetermined length that separates extreme …
Advances in prevention of cervical cancer and other human papillomavirus-related diseases
IH Frazer, JT Cox, EJ Mayeaux Jr… - The Pediatric …, 2006 - journals.lww.com
In theory, recognition that a pandemic infection is responsible for more than half a million
cancer cases each year would attract huge media attention, and infection control would …
cancer cases each year would attract huge media attention, and infection control would …
[HTML][HTML] Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
SM Garland, M Hernandez-Avila… - … England Journal of …, 2007 - Mass Medical Soc
Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …
quadrivalent vaccine in preventing anogenital diseases associated with human …
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Background Vaccination against the most common oncogenic human papillomavirus (HPV)
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …
[HTML][HTML] Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
AR Giuliano, JM Palefsky, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …
[HTML][HTML] HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
JM Palefsky, AR Giuliano, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a …
EA Joura, S Leodolter, M Hernandez-Avila… - The Lancet, 2007 - thelancet.com
Background Vulval and vaginal cancers among younger women are often related to
infection with human papillomavirus (HPV). These cancers are preceded by high-grade …
infection with human papillomavirus (HPV). These cancers are preceded by high-grade …
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine …
DR Brown, SK Kjaer, K Sigurdsson… - The Journal of …, 2009 - academic.oup.com
Abstract Background Human papillomavirus (HPV)–6/11/16/18 vaccine reduces the risk of
HPV-6/11/16/18–related cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in …
HPV-6/11/16/18–related cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in …
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
N Muñoz, SK Kjaer, K Sigurdsson… - Journal of the …, 2010 - academic.oup.com
Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …